Establishment Labs Announces Preliminary Fourth Quarter and Fiscal Year 2021 Revenue

SANTA BARBARA, Calif., January 10, 2022–Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today reported preliminary unaudited revenue for the three months and fiscal year ended December 31, 2021.